Y-Intercept (HK)’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-124,056
Closed -$10.2M 1737
2025
Q4
$10.2M Buy
124,056
+108,695
+708% +$8.47M 0.23% 65
2025
Q3
$1.15M Buy
+15,361
New +$1.15M 0.03% 910
2024
Q4
Sell
-58,284
Closed -$5.47M 1356
2024
Q3
$5.47M Buy
+58,284
New +$4.89M 0.33% 43
2024
Q2
Sell
-2,783
Closed -$253K 1563
2024
Q1
$253K Sell
2,783
-20,707
-88% -$1.72M 0.02% 1045
2023
Q4
$1.82M Buy
+23,490
New +$1.65M 0.17% 149
2023
Q2
Sell
-9,800
Closed -$804K 1428
2023
Q1
$804K Buy
+9,800
New +$700K 0.09% 319

Other funds holding GEHC

Y-Intercept (HK)'s GEHC Position: Q1 2026 in Review

Y-Intercept (HK) sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 124,056 shares — an estimated $10.2M sold.

Y-Intercept (HK) first reported a position in GEHC in Q1 2023 and held it in 6 quarters. The position peaked at $10.2M in Q4 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Y-Intercept (HK) reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 124,056 GE HealthCare shares in Q1 2026, an estimated $10.2M.
  • Y-Intercept (HK) first reported a position in GE HealthCare in Q1 2023 and held it in 6 quarters.
  • Y-Intercept (HK)'s GE HealthCare position peaked at $10.2M in Q4 2025.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.